But as time passed, he noticed that he became short ... fellow cardiologist and determined that the best option was a TAVR. His recovery was relatively fast — he went home the next day and ...
CASE DETAILS: According to the complaint, defendants provided investors with material information concerning Edwards' expected revenue for the fiscal year 2024, particularly as it related to the ...
More specifically, throughout the Class Period, Edwards Lifesciences repeatedly assured investors that its TAVR platform was positioned for “strong sustainable growth” well into the future ...
Earlier this month, the German mechanical engineering industry association VDMA expressed similar hopes of recovery in time for K. In the meantime, orders for German plastics and rubber machinery ...